Citation Impact

Citing Papers

Melatonin attenuates D‐galactose‐induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NFKB/JNK signaling pathway in aging mouse model
2014 Standout
Regenerative Scar-Free Skin Wound Healing
2019
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles
2020
Ferroptosis: molecular mechanisms and health implications
2020 Standout
d-Galactose-induced accelerated aging model: an overview
2019 Standout
The Amyloid-β Pathway in Alzheimer’s Disease
2021
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Mammalian lipoxygenases and their biological relevance
2014
Synaptic Impairment in Alzheimer’s Disease: A Dysregulated Symphony
2017
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin
2011
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells
2016 StandoutNobel
Galactose toxicity in animals
2009
Effectiveness of High-Intensity Interval Training (HIT) and Continuous Endurance Training for VO2max Improvements: A Systematic Review and Meta-Analysis of Controlled Trials
2015
Ginsenoside Rg1 Prevents Cognitive Impairment and Hippocampus Senescence in a Rat Model of D-Galactose-Induced Aging
2014
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Extraction and application of keratin from natural resources: a review
2021 Standout
Anthocyanins Reversed D-Galactose-Induced Oxidative Stress and Neuroinflammation Mediated Cognitive Impairment in Adult Rats
2016 Standout
Melatonin improves d‐galactose‐induced aging effects on behavior, neurogenesis, and lipid peroxidation in the mouse dentate gyrus via increasing pCREB expression
2011
The Lipoxygenases: Their Regulation and Implication in Alzheimer’s Disease
2015
5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer’s disease
2020
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Lipids and Alzheimer’s Disease
2020
Lecanemab in Early Alzheimer’s Disease
2022 Standout
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
Smart wound dressings for wound healing
2021 Standout
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Oxidative Stress in Ageing and Chronic Degenerative Pathologies: Molecular Mechanisms Involved in Counteracting Oxidative Stress and Chronic Inflammation
2022
Physiological adaptations to interval training and the role of exercise intensity
2016 Standout
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
2019 Standout
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Differential cell death decisions in the testis: evidence for an exclusive window of ferroptosis in round spermatids
2019

Works of Jin Chu being referenced

Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer’s disease mouse model
2012
Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice
2012
Amelioration of the Alzheimer's Disease Phenotype by Absence of 12/15-Lipoxygenase
2010
Zileuton Improves Memory Deficits, Amyloid and Tau Pathology in a Mouse Model of Alzheimer’s Disease with Plaques and Tangles
2013
Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer’s disease
2017
Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, Aβ and tau neuropathology in the triple-transgenic mice
2015
Involvement of 5-Lipoxygenase in the Corticosteroid-Dependent Amyloid Beta Formation: In Vitro and In Vivo Evidence
2011
5‐lipoxygenase as an endogenous modulator of amyloid beta formation in vivo
2010
Temporal Gene Expression Profile in Hippocampus of Mice Treated with d-galactose
2007
ADM Scaffolds Generate a Pro-regenerative Microenvironment During Full-Thickness Cutaneous Wound Healing Through M2 Macrophage Polarization via Lamtor1
2018
Modulation of lipopolysaccharide-induced memory insult, γ-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase
2013
The retromer complex system in a transgenic mouse model of AD: influence of age
2017
5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5
2013
FLAP pharmacological blockade modulates metabolism of endogenous tau in vivo 
2013
Icariin reduces α-synuclein over-expression by promoting α-synuclein degradation
2015
Gamma Secretase-Activating Protein Is a Substrate for Caspase-3: Implications for Alzheimer’s Disease
2014
Regulation of gamma-secretase activating protein by the 5Lipoxygenase: in vitro and in vivo evidence
2015
The Influence of 5-Lipoxygenase on Alzheimer’s Disease-Related Tau Pathology: In Vivo and In Vitro Evidence
2013
Knockout of 5‐lipoxygenase prevents dexamethasone‐induced tau pathology in 3xTg mice
2013
The 12‐15‐lipoxygenase is a modulator of Alzheimer's‐related tau pathology in vivo
2013
Rankless by CCL
2026